デフォルト表紙
市場調査レポート
商品コード
1429929

軟骨再生医療の世界市場レポート2024

Regenerative Medicine For Cartilage Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
軟骨再生医療の世界市場レポート2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

軟骨再生医療の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.9%の年間複合成長率(CAGR)で56億4,000万米ドルに成長すると予想されます。再生医療市場の予測期間の成長は、臓器移植の需要の増加、ヘルスケア費の増加、再生医療の技術進歩、再生医療調査への投資の増加、ライフスタイルの変化に起因すると考えられます。予測期間中に予想される主な動向には、間葉系幹細胞技術の利用拡大、新規遺伝子治療技術の使用に関する研究開発の強化、技術移転と臨床応用の進歩、戦略的提携、パートナーシップ、協定の増加が含まれます。新しい企業の出現と成長、再生医療としての軟骨修復における注射用ハイドロゲルの役割、世界の調査の取り組みと資金提供などです。

世界中で変形性関節症の有病率がエスカレートしており、軟骨再生医療市場の主要な促進要因となることが予想されます。変形性関節症は、主に関節軟骨に影響を及ぼす変性関節疾患で、関節炎財団の予測によれば、2050年までに世界中で少なくとも1億3,000万人が罹患すると予想されています。自家軟骨細胞移植および足場インプラントは、変形性関節症に対して一般的に使用される治療法の一つです。したがって、変形性関節症の発生率の増加により、軟骨再生医療の需要が高まると予想されます。

慢性疾患の急増により、軟骨再生医療市場の成長が促進される見込みです。慢性疾患は長期間にわたり、多くの場合は生涯を通じて持続するため、軟骨再生医療を含む医療専門ソリューションのニーズにおいて極めて重要な役割を果たします。慢性疾患、特に筋骨格系に影響を与える疾患の蔓延は、再生医療の分野にとって良い兆候です。世界保健機関によると、世界の年間死亡者数4,100万人のうち74%は非感染性疾患(NCD)または慢性疾患が原因です。特に、1,790万人が心血管疾患、930万人ががん、410万人が慢性呼吸器疾患、200万人が糖尿病で死亡しています。その結果、慢性疾患の発生率の増加が軟骨再生医療市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の軟骨再生医療市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 細胞ベース
  • 遺伝子ベース
  • 組織ベース
  • 世界の軟骨再生医療市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 筋骨格系
  • 腫瘍学
  • 歯科
  • 創傷ケア
  • その他
  • 世界の軟骨再生医療市場、最終用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 外来手術センター
  • 病院と診療所
  • その他の最終用途

第7章 地域および国の分析

  • 世界の軟骨再生医療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の軟骨再生医療市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 軟骨再生医療市場の競合情勢
  • 軟骨再生医療市場の企業プロファイル
    • Smith &Nephew plc
    • Integra LifeSciences
    • Stryker Corporation
    • MiMedx Group, Inc.
    • Zimmer Biomet Holdings Inc.

第31章 その他の大手および革新的な企業

  • B. Braun Melsungen AG
  • AbbVie
  • CONMED Corporation
  • Arthrex Inc.
  • Baxter International Inc.
  • China Regenerative Medicine International
  • AstraZenaca
  • ABLbio
  • Adimmune
  • Henlius
  • Innovent Biologics
  • Bio-Thera
  • Hisun Pharma
  • 3SBio
  • Biocon

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14900

Regenerative medicine for cartilage involves a treatment administered during surgery to repair damaged knee cartilage using cells produced by the body that can generate cartilage. The process entails obtaining a biopsy to collect chondrocytes, the cells responsible for cartilage production. These chondrocytes are then multiplied in a laboratory setting before being implanted into the injured area as part of the surgical procedure.

The primary types of regenerative medicine for cartilage include cell-based, gene-based, and tissue-based approaches. Cell-based methods typically encompass processes, technologies, or products that involve living cells or are derived from them. They find application in various medical fields such as musculoskeletal, oncology, dental, wound care, among others, and are utilized by different end-users including ambulatory surgical centers, hospitals and clinics, and others.

The regenerative medicine for cartilage market research report is one of a series of new reports from The Business Research Company that provides regenerative medicine for cartilage market statistics, including regenerative medicine for cartilage industry global market size, regional shares, competitors with regenerative medicine for cartilage market share, detailed regenerative medicine for cartilage market segments, market trends and opportunities, and any further data you may need to thrive in the regenerative medicine for cartilage industry. This regenerative medicine for cartilage market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The regenerative medicine for cartilage market size has grown strongly in recent years. It will grow from $4.24 billion in 2023 to $4.48 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The expansion observed during the historical period in the regenerative medicine market can be attributed to the rising prevalence of chronic diseases, growth in emerging markets, the implementation of the 21st Century Cures Act, rapid growth in the aging population, and improvements in healthcare awareness and expenditure.

The regenerative medicine for cartilage market size is expected to see strong growth in the next few years. It will grow to $5.64 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The anticipated growth in the forecast period in the regenerative medicine market can be attributed to the increasing demand for organ transplantations, a rise in healthcare expenditure, technological advancements in regenerative medicines, increased investments in regenerative medicine research, and changes in lifestyles. Major trends expected during the forecast period include the growing utilization of mesenchymal stem cell technology, heightened research and development on the use of novel gene therapy techniques, advancements in technology transfer and clinical translation, a rise in strategic collaborations, partnerships, and agreements, the emergence and growth of new companies, the role of injectable hydrogel in cartilage repair as a regenerative medicine, and global research initiatives and funding.

The escalating prevalence of osteoarthritis worldwide is set to be a key driver for the regenerative medicine for cartilage market. Osteoarthritis, a degenerative joint disorder primarily affecting the articular cartilage, is anticipated to impact at least 130 million individuals globally by 2050, as projected by the Arthritis Foundation. Autologous chondrocyte implantation and scaffold implants are among the commonly employed treatments for osteoarthritis. Consequently, the growing incidence of osteoarthritis is expected to fuel the demand for regenerative medicine for cartilage.

The surge in chronic diseases is poised to propel the growth of the regenerative medicine for cartilage market. Chronic diseases, enduring over an extended period and often throughout a person's lifetime, play a pivotal role in the need for medical specialty solutions, including regenerative medicine for cartilage. The prevalence of chronic diseases, particularly those impacting the musculoskeletal system, bodes well for the field of regenerative medicine. According to the World Health Organization, 74% of the 41 million annual deaths globally are caused by non-communicable diseases (NCDs) or chronic diseases. Notably, 17.9 million deaths result from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the increasing incidence of chronic diseases is driving the growth of the regenerative medicine for cartilage market.

Emerging trends in regenerative medicine for cartilage include tissue engineering and stem cell therapy. The advancement of tissue engineering technology offers promising prospects for cartilage regeneration. Stem cell therapy, with its advantages over traditional orthopedic treatments, is gaining prominence for reducing knee pain and enhancing knee cartilage regeneration and repair. Technologies such as platelet-rich plasma (PRP) therapy, incorporating growth factors, are utilized to effectively promote tissue regeneration. Market players are actively introducing new technologies to stay competitive in the evolving landscape of regenerative medicine for cartilage.

Collaborations between pharmaceutical companies and government entities are on the rise, fostering partnerships aimed at providing funding and implementing incentive programs for the research and development (R&D) of regenerative medicine for cartilage. These collaborations offer financial and technical support across various clinical development phases. For instance, in 2021, the Government of Canada, along with several provincial governments, announced multiple investment initiatives to establish flexible biomanufacturing capacity and new biotech innovation hubs. Additionally, a $45 million investment was earmarked from 2022-2023 to support stem cell and regenerative medicine research through the Stem Cell Network.

In December 2021, Cesca Therapeutics Inc., a U.S.-based company specializing in automated cellular processing and autologous cell therapies for regenerative medicine, acquired the remaining 20% equity share of ThermoGenesis Corp. for an undisclosed amount. This strategic move allows Cesca to concentrate on its CAR-TX press cellular processing platform, enhancing efficiency in cellular manufacturing. ThermoGenesis, a healthcare company, focuses on developing automated technologies for cell-based therapeutics and bioprocessing.

Major companies operating in the regenerative medicine for cartilage market report are Smith & Nephew PLC, Integra LifeSciences, Stryker Corporation, MiMedx Group, Inc., Zimmer Biomet Holdings Inc., B. Braun Melsungen AG, AbbVie, CONMED Corporation, Arthrex Inc., Baxter International Inc.,, China Regenerative Medicine International, AstraZenaca, ABLbio, Adimmune, Henlius, Innovent Biologics, Bio-Thera, Hisun Pharma, 3SBio, Biocon, Dr.Reddy's, Mylan, Kyowa Hakko Kirin, Takeda, Mitsubishi Tanabe, Cellgenix Gmbh, BioTissue Technologies, Corin Group, Medical Import Ltd., Lucideon, Orthonika, Merete, 3di GmbH, Aditus Medical GmbH, Anton Hipp GmbH, AREX SAS, Acelity L.P. Inc., Celgene Corporation, StemCells, Inc., Organogenesis Inc., NuVasive, Inc., Japan Tissue Engineering Co., Ltd., Advantagene, Inc., Mesoblast Ltd., Globus Medical, DePuy Synthes, Cryolife Inc., Johnson & Johnson, Medtronic PLC, Rti Surgical, CartiHeal, Inc., DJO Global Inc., Wright Medical Group, Auxein, Aesculap, Inc., AMEGA Biotech, BioMarin Pharmaceutical, Ache Laboratorios Farmaceuticos, Myralis Industria Farmaceuticaa, Biosonda Biotechnology, Ipsum Clinical, Steris Applied Sterilization Technologies

Europe was the largest region in regenerative medicine for cartilage in 2023. The regions covered in the regenerative medicine for cartilage market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the regenerative medicine for cartilage market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The regenerative medicine for cartilage market consists of sales of cartilage regeneration, platelet-rich plasma (PRP), and prolotherapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Regenerative Medicine For Cartilage Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on regenerative medicine for cartilage market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for regenerative medicine for cartilage? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The regenerative medicine for cartilage market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Cell Based; Gene Based; Tissue Based
  • 2) By End-Use: Ambulatory Surgical Centers; Hospitals And Clinics; Others
  • 3) By Application: Musculoskeletal; Oncology; Dental; Wound Care; Others
  • Companies Mentioned: Smith & Nephew plc; Integra LifeSciences; Stryker Corporation; MiMedx Group, Inc.; Zimmer Biomet Holdings Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Regenerative Medicine For Cartilage Market Characteristics

3. Regenerative Medicine For Cartilage Market Trends And Strategies

4. Regenerative Medicine For Cartilage Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Regenerative Medicine For Cartilage Market Size and Growth

  • 5.1. Global Regenerative Medicine For Cartilage Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Regenerative Medicine For Cartilage Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Regenerative Medicine For Cartilage Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Regenerative Medicine For Cartilage Market Segmentation

  • 6.1. Global Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cell Based
  • Gene Based
  • Tissue Based
  • 6.2. Global Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Musculoskeletal
  • Oncology
  • Dental
  • Wound Care
  • Others
  • 6.3. Global Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Ambulatory Surgical Centers
  • Hospitals And Clinics
  • Other End-Uses

7. Regenerative Medicine For Cartilage Market Regional And Country Analysis

  • 7.1. Global Regenerative Medicine For Cartilage Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Regenerative Medicine For Cartilage Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Regenerative Medicine For Cartilage Market

  • 8.1. Asia-Pacific Regenerative Medicine For Cartilage Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Regenerative Medicine For Cartilage Market

  • 9.1. China Regenerative Medicine For Cartilage Market Overview
  • 9.2. China Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Regenerative Medicine For Cartilage Market

  • 10.1. India Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Regenerative Medicine For Cartilage Market

  • 11.1. Japan Regenerative Medicine For Cartilage Market Overview
  • 11.2. Japan Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Regenerative Medicine For Cartilage Market

  • 12.1. Australia Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Regenerative Medicine For Cartilage Market

  • 13.1. Indonesia Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Regenerative Medicine For Cartilage Market

  • 14.1. South Korea Regenerative Medicine For Cartilage Market Overview
  • 14.2. South Korea Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Regenerative Medicine For Cartilage Market

  • 15.1. Western Europe Regenerative Medicine For Cartilage Market Overview
  • 15.2. Western Europe Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Regenerative Medicine For Cartilage Market

  • 16.1. UK Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Regenerative Medicine For Cartilage Market

  • 17.1. Germany Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Regenerative Medicine For Cartilage Market

  • 18.1. France Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Regenerative Medicine For Cartilage Market

  • 19.1. Italy Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Regenerative Medicine For Cartilage Market

  • 20.1. Spain Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Regenerative Medicine For Cartilage Market

  • 21.1. Eastern Europe Regenerative Medicine For Cartilage Market Overview
  • 21.2. Eastern Europe Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Regenerative Medicine For Cartilage Market

  • 22.1. Russia Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Regenerative Medicine For Cartilage Market

  • 23.1. North America Regenerative Medicine For Cartilage Market Overview
  • 23.2. North America Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Regenerative Medicine For Cartilage Market

  • 24.1. USA Regenerative Medicine For Cartilage Market Overview
  • 24.2. USA Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Regenerative Medicine For Cartilage Market

  • 25.1. Canada Regenerative Medicine For Cartilage Market Overview
  • 25.2. Canada Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Regenerative Medicine For Cartilage Market

  • 26.1. South America Regenerative Medicine For Cartilage Market Overview
  • 26.2. South America Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Regenerative Medicine For Cartilage Market

  • 27.1. Brazil Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Regenerative Medicine For Cartilage Market

  • 28.1. Middle East Regenerative Medicine For Cartilage Market Overview
  • 28.2. Middle East Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Regenerative Medicine For Cartilage Market

  • 29.1. Africa Regenerative Medicine For Cartilage Market Overview
  • 29.2. Africa Regenerative Medicine For Cartilage Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Regenerative Medicine For Cartilage Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Regenerative Medicine For Cartilage Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Regenerative Medicine For Cartilage Market Competitive Landscape And Company Profiles

  • 30.1. Regenerative Medicine For Cartilage Market Competitive Landscape
  • 30.2. Regenerative Medicine For Cartilage Market Company Profiles
    • 30.2.1. Smith & Nephew plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Integra LifeSciences
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Stryker Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. MiMedx Group, Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Zimmer Biomet Holdings Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Regenerative Medicine For Cartilage Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. AbbVie
  • 31.3. CONMED Corporation
  • 31.4. Arthrex Inc.
  • 31.5. Baxter International Inc.
  • 31.6. China Regenerative Medicine International
  • 31.7. AstraZenaca
  • 31.8. ABLbio
  • 31.9. Adimmune
  • 31.10. Henlius
  • 31.11. Innovent Biologics
  • 31.12. Bio-Thera
  • 31.13. Hisun Pharma
  • 31.14. 3SBio
  • 31.15. Biocon

32. Global Regenerative Medicine For Cartilage Market Competitive Benchmarking

33. Global Regenerative Medicine For Cartilage Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Regenerative Medicine For Cartilage Market

35. Regenerative Medicine For Cartilage Market Future Outlook and Potential Analysis

  • 35.1 Regenerative Medicine For Cartilage Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Regenerative Medicine For Cartilage Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Regenerative Medicine For Cartilage Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer